Hypoxic Mechanisms in Alzheimer's Disease Pathogenesis

Alzheimer’s disease is increasingly recognised as a disorder in which impaired oxygen delivery and utilisation contribute to the cascade of neurodegenerative events. Vascular dysfunction, diminished cerebral blood flow and microvascular rarefaction promote chronic hypoxia within vulnerable regions of the brain. In response to reduced oxygen tension, stabilisation of hypoxia-inducible factors triggers transcriptional programmes that up-regulate amyloidogenic processing of the amyloid precursor protein, enhance β-secretase activity and foster accumulation of amyloid-β. Concurrently, hypoxia-driven oxidative stress and mitochondrial dysfunction accelerate tau hyperphosphorylation and disrupt synaptic integrity. Epigenetic modifications under hypoxic conditions can down-regulate key Aβ-degrading enzymes, further tipping the balance towards plaque deposition. In parallel, oxygen deprivation skews microglial phenotypes towards a pro-inflammatory state, fuelling chronic neuroinflammation and neuronal loss. Emerging evidence also implicates systemic changes such as red blood cell deformability and reduced oxygen saturation as early indicators of incipient pathology. Collectively, these mechanisms interconnect vascular, metabolic and inflammatory pathways, underscoring hypoxia as both a driver and amplifier of Alzheimer’s pathology and suggesting novel avenues for intervention.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Hypoxic Mechanisms in Alzheimer's Disease Pathogenesis publication trend

The graph below shows the total number of articles in hypoxic mechanisms in alzheimer's disease pathogenesis across all publications each year (not limited to Nature Index journals).

Technical terms

Hypoxia: A state of reduced oxygen availability in tissues leading to adaptive and pathological cellular responses.

Hypoxia-inducible factor 1α (HIF-1α): A transcription factor that orchestrates gene expression in response to low oxygen tension.

Beta-secretase (BACE1): An enzyme that initiates the amyloidogenic cleavage of the amyloid precursor protein, generating amyloid-β peptides.

Amyloid-β (Aβ): A peptide fragment derived from amyloid precursor protein cleavage that accumulates as extracellular plaques in Alzheimer’s disease.

Tau hyperphosphorylation: Excessive addition of phosphate groups to tau protein, leading to neurofibrillary tangle formation and microtubule destabilisation.

Cerebral blood flow (CBF): The volume of blood passing through the brain’s vasculature per unit time, essential for oxygen and nutrient delivery.

Neuroinflammation: The activation of glial cells and release of inflammatory mediators within the central nervous system.

Reactive oxygen species (ROS): Chemically reactive molecules containing oxygen that can damage cellular structures when produced in excess.

References

1. APPswe/PS1ΔE9 mice exhibit low oxygen saturation and alterations of erythrocytes preceding the neuropathology and cognitive deficiency during Alzheimer's disease. CNS Neuroscience & Therapeutics (2023).
2. Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation*. Journal of Biological Chemistry (2007).
3. Hypoxia-Induced Down-Regulation of Neprilysin by Histone Modification in Mouse Primary Cortical and Hippocampal Neurons. PLOS ONE (2011).
4. Acute Hypoxia Induced an Imbalanced M1/M2 Activation of Microglia through NF-κB Signaling in Alzheimer’s Disease Mice and Wild-Type Littermates. Frontiers in Aging Neuroscience (2017).
5. The Role of Oxygen Homeostasis and the HIF-1 Factor in the Development of Neurodegeneration. International Journal of Molecular Sciences (2024).
6. Oxidative Stress and Hypoxia Contribute to Alzheimer′s Disease Pathogenesis: Two Sides of the Same Coin. The Scientific World JOURNAL (2009).